All results showed that Aidi injection could significantly improve the percentage of CD3+ T cells, CD4+ T cells, CD8+ T cells, and NK cells, and the CD4+/CD8+ T cells ratio in the peripheral blood of patients with NSCLC. This evidence concerns the gene CD8A and non-small cell lung carcinoma.